Category Archives: Replicel

RCH-01, Replicel

Replicel’s update from the Stem Cell on the Mesa conference

4 Comments
RepliCel
RepliCel.

Replicel gave its presentation today at the Stem Cell on the Mesa Conference. Although my regular day job meant that I missed the live webcast, Replicel kindly Tweeted its presentation summary to me.

Replicel Update from the Stem Cell on the Mesa Conference

I was expecting the presentation to be dominated by the company’s achilles tendinosis related work, but there was a good amount of information on the male pattern baldness work (RCH-01) too. As previously discussed on this blog, their phase 2 trials began in Germany in 2014. However, it seems like the Japanese trials have been delayed and moved from late 2014 to the first half of 2015. Both trials will last for 1 year.

They also presented their completed 6-month phase 1 trial results. Average density across all participants increased 11.8 percent with no side effects. I wonder if this average density increase figure will go up significantly as they increase dosage and time frame? I would hope so.

FYI — today and tomorrow, you can listen to some excellent track 1 webcasts and track 2 webcasts from the Mesa Conference website. The future can’t come fast enough.

Gail Naughton, Histogen, Replicel

Histogen and Replicel Present at Stem Cell Meeting

1 Comment

If you live anywhere near San Diego (now one of the world’s leading biotech hubs), the “Stem Cell Meeting on the Mesa” from October 7-9, 2014 is worth attending if you can somehow get in.

Stem Cell Meeting on the Mesa

Surprisingly, both Histogen (based in San Diego) and Replicel (based in Vancouver, Canada) are presenting at this Stem Cell Meeting on the Mesa event. For more information, scroll all the way down on the detailed descriptions page of each company’s presentation.

Histogen’s presentation will be given by CEO Gail Naughton and Replicel’s presentation will be given by CEO David Hall. I wonder if these two competitors will talk to each other at lunch?

I do not expect either company’s hair loss research related presentation to divulge anything new or ground breaking. However, the overall conference is extremely interesting in terms of the incredible advances that are now being made in regenerative medicine, gene therapy, stem cell research and more. Many of the speakers are renowned leaders in their fields.

Also check out this interesting recent article on Replicel.